SCHEMBL29368491

SCHEMBL29368491

C[C@H](N)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O

nearest known ligand 0.83

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 13/20 0.83
SSTR1 P30872 11/20 0.83
SSTR2 P30874 10/20 0.83
SSTR5 P35346 10/20 0.83
SSTR3 P32745 10/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Somatostatin Receptor Ligand SCHEMBL16186775 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin SCHEMBL29350200 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL3046327 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL31432768 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL8482 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL29386529 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL12548326 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL16062971 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin SCHEMBL21361053 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3
Somatostatin Receptor Ligand SCHEMBL3839184 1.00 SSTR4 (0.83) SSTR4SSTR1SSTR2SSTR5SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 657 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4389012-B1 TACTILE SENSOR COVER AND MANUFACTURING METHOD AND MEDICAL DEVICE Siemens Healthineers Ag (DE) 2026-02-04 EP claimed
US-20250325626-A1 LIPID-CONTROLLED RELEASE COMPOSITIONS CAMURUS AB (SE) 2025-10-23 US claimed
US-RE50619-E1 Emergency power source Shenzen Carku Technology Co., Ltd. (CN) 2025-10-07 US claimed
CN-120087996-A Venue gradient pricing method, system and equipment based on real-time dynamic data 山东浪潮智慧文旅产业发展有限公司 2025-06-03 CN claimed
CN-120087946-A Predictive maintenance system and method for robot 济宁职业技术学院 2025-06-03 CN claimed
CN-120072296-A Lung cancer risk early warning system based on multi-factor supporting information 耿迪 2025-05-30 CN claimed
CN-120015290-A Anesthesia evaluation decision-making system and method based on brain department 中国人民解放军总医院海南医院 2025-05-16 CN claimed
CN-119984412-A Egg chicken breeding environment monitoring system 正大蛋业(山东)有限公司 2025-05-13 CN claimed
CN-222852247-U Digital power amplifier dynamic overcurrent protection circuit 广东保伦电子股份有限公司 2025-05-09 CN claimed
CN-222802557-U TWS charging bin simple discrete component small-current charging practical circuit 湖南炬神电子有限公司 2025-04-25 CN claimed
CN-217213898-U Binocular vision-based monitoring and alarm system for preventing children from leaving behind 桂林电子科技大学 2022-08-16 CN claimed
CN-114878653-A Electrochemical excitation unit and application thereof in electrochemical luminescence detection 华南师范大学 2022-08-09 CN claimed
CN-217133845-U Explosion-proof type electric power efficiency acquisition terminal towards chemical industry enterprise 南京再造科技有限公司 2022-08-05 CN claimed
CN-111617250-B Multi-ligand drug couplet and application thereof 同宜医药(苏州)有限公司 2022-07-01 CN claimed
EP-3236937-B1 CONTROLLED-RELEASE FORMULATIONS CAMURUS AB (SE) 2022-05-04 EP claimed
CN-114410799-A PCR-CRISPR/Cas13 a-based treponema pallidum detection method 南方医科大学皮肤病医院(广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心) 2022-04-29 CN claimed
CN-216366329-U Conductive mask 深圳市臻上科技发展有限公司 2022-04-26 CN claimed
CN-114147969-A Model preprocessing annular texture blanking method, device, equipment and storage medium 深圳市创必得科技有限公司 2022-03-08 CN claimed
CN-215813811-U Exchange intelligent junction box 南京三一光电科技有限公司 2022-02-11 CN claimed
CN-114002974-A Direct current intelligence junction box 南京三一光电科技有限公司 2022-02-01 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325626-A1 LIPID-CONTROLLED RELEASE COMPOSITIONS DAGLA, MGLL, DAGLB SSTR4 954/4885SSTR1 863/4885SSTR2 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.